NCT06122246 PRESSURE CHECK: Find Your Path to Better Health
| NCT ID | NCT06122246 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,440 participants |
| Start Date | 2024-04-14 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,440 participants in total. It began in 2024-04-14 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to develop the evidence for a sustainable, community-partnered, multi-level health system strategy to improve blood pressure control. Two team-based approaches are being tested: 1) a medical model of remote BP management (RBPM) alone, and 2) RBPM plus a social model with a community health worker (CHW). These 2 strategies are being compared with a standard community screening program with referral to primary care.
Eligibility Criteria
Inclusion Criteria: * Elevated BP, defined as an average resting BP of \>=135/85 mmHg based on 3 consecutive blood pressure readings Exclusion Criteria: * People who are pregnant or who plan to become pregnant in the next 6 months at study entry * Those that have end stage renal disease on dialysis * People receiving active chemotherapy
Contact & Investigator
Erica Spatz, MD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06122246 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06122246 currently recruiting?
Yes, NCT06122246 is actively recruiting participants. Contact the research team at bonnie.garmisa@yale.edu for enrollment information.
Where is the NCT06122246 trial being conducted?
This trial is being conducted at New Haven, United States, Boston, United States, Houston, United States, Norfolk, United States.
Who is sponsoring the NCT06122246 clinical trial?
NCT06122246 is sponsored by Yale University. The principal investigator is Erica Spatz, MD at Yale University. The trial plans to enroll 1,440 participants.